Skip to search formSkip to main contentSkip to account menu

Colestipol

Known as: Colestipol [Chemical/Ingredient], Epichlorohydrin-tetraethylenepentamine polymer, Colestipolum 
A positively charged, non-digestible, triamine and epoxypropane copolymer anion-exchange resin that binds to bile acids in the intestine to form an… 
National Institutes of Health

Related topics

Related topics

22 relations

Broader (4)

Anion Exchange ResinsAntilipemic agentHypolipidemic AgentsSequestering Agents
Binding Activity [MoA]Cholestasis, ExtrahepaticColestipol HydrochlorideColestipol Hydrochloride 1000 MG Oral Tablet [Colestid]

Narrower (1)

Colestid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The HALTS trial--halting atherosclerosis or halted too early?
In patients with elevated cholesterol levels, statin therapy reduces the incidence of cardiovascular events by 25 to 45%. Despite… 
1995
1995
Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
1992
1992
Evaluation of Colestipol/Niacin Therapy With Computer‐Derived Coronary End Point Measures: A Comparison of Different Measures of Treatment Effect
BackgroundThe Cholesterol Lowering Atherosclerosis Study has demonstrated beneficial effect of colestipol/niacin on coronary… 
Review
1988
Review
1988
Management of lipids in primary and secondary prevention of cardiovascular diseases.
Highly Cited
1988
Highly Cited
1988
Combination drug therapy for familial combined hyperlipidemia.
STUDY OBJECTIVE To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial… 
Highly Cited
1986
Highly Cited
1986
Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
Highly Cited
1979
Highly Cited
1979
Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Long-term effects of diet and colestipol (a bile acid sequestrant) were studied in 25 patients with familial type II… 
Highly Cited
1976
Highly Cited
1976
The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Bile acid-binding resins, currently used for the treatment of Type II hyperlipoproteinemia, decrease LDL cholesterol by 25 to 35… 
1974
1974
Colestipol and clofibrate in hypercholesterolemia
The effects of colestipol, clofibrate, and placebo were compared in 30 patients with serum cholesterollevels higher than 250 and… 
1973
1973
Effect of colestipol on gastrointestinal absorption of chlorothiazide in man
The effect of colestipol on gastrointestinal absorption of chlorothiazide was studied in 10 adult patients. A 58% decrease in 24… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)